- Display 15 Products per page
Published: June 18, 2013 | Price: $1,500.00 – $3,000.00
This report, Out of Pocket Healthcare 2013, is Kalorama's latest estimates for the amount spent by consumers on their own (through cash payments, credit cards, FSAs and finance programs) for healthcare services. The out-of -pocket market for the following areas are included: Doctors Pharmaceuticals Hospitals ER Vision Dental Elective Procedures The report estimates the amount spent in cash/checks and the amount financed. As part of the report, spending for the following healthcare costs are provided for years 2008-2016: Premiums Co...Published: February 2, 2015 | Price: $1,995.00 – $3,995.00
The US Market for Rx to OTC Switches Prescription products that are marketed as consumer products are known as Rx-to-OTC. They represent an important part of pharmaceutical strategy and a growing market. This report, The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available. Patient-consumer awareness of health issues is driving the Rx-to-OTC market. Consumers are more prepared to take responsibility for their own health and are willing to purchase medicines over the...Published: May 1, 2010 | Price: $3,995.00 – $7,990.00
Patient monitoring systems are emerging in response to increased healthcare needs of an aging population, new wireless technologies, better video and monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness. Of these new high-tech patient monitoring systems, nearly all focus on some form of wireless or remote patient monitoring. Advances in remote patient monitoring include new peripherals, real-time audio and video for “face-to-face” interaction between clinicians and patients, wireless communication, systems that “sort” the vast...Published: May 26, 2022 | Price: $5,000.00 – $10,000.00
Direct to consumer laboratory testing is also known as patient-ordered laboratory testing. A variety of tests are now available for direct to consumer testing. The growing market for direct-to-consumer laboratory testing may promote awareness of health issues and genetic diseases, which will allow patients to take a more proactive role in their healthcare. With advances in technology, the completion of the sequencing of the human genome and the pressures of the pandemic, direct to consumer lab testing is becoming increasingly...Published: October 1, 2010 | Price: $2,995.00 – $5,990.00
Infusion pumps are used to infuse necessary fluids, which includes medications and/or nutrients, to a patient’s circulatory system. This Kalorama Information report, Infusion Pump Markets (Large Volume, Ambulatory, Disposable, Syringe, and Specialty Infusion Pumps) covers markets for these products in several product segments. Estimates and Forecasts of Infusion Pump Markets For the purpose of this study, we have classified two general types of infusion pumps: General Purpose Infusion Pumps and Specialty Infusion Pumps General purpose infusion pumps are used in...Published: December 1, 2008 | Price: $995.00 – $1,990.00
The substances utilized for what is commonly referred to as 'protein therapeutics' have one thing in common --- they are all composed primarily of á-amino acids; and these á-amino acids are linked together by a distinct chemical bond known as a “peptide” bond. Used in a variety of areas of medicine, they are among the most interesting pharmaceutical markets. Above-Average Growth Rates What makes protein therapeutics interesting? The market for protein-based therapeutics is one that is significant in its size...Published: February 23, 2022 | Price: $5,000.00 – $10,000.00
The World Market for Veterinary Diagnostics, 5th Edition examines the worldwide veterinary diagnostics market through the performance of its two component markets of companion animal and food animal diagnostics. The report provides analysis of major veterinary disease markets as well as overall market performance and development. Data points provided include: Total Global Animal Diagnostic Testing Market, 2021-2026 (in millions $ at manufacturer level) Global Veterinary Diagnostic Testing Market Share by Region (%) 2021 (US, Europe, Asia Pacific, RoW) Food Animal...Published: October 1, 2007 | Price: $995.00 – $5,990.00
Retail clinics, also known as convenience clinics, represent a disruptive innovation into the U.S. health care market, which evolved from and is uniquely positioned to benefit from the health care system’s shortcomings. These clinics present a new opportunity for retail outlets to earn more revenue from rents and 'indirect' revenues from sales to the retail store as a result of a clinic visit. But there is also an opportunity for diagnostic and pharmaceutical companies to capitalize on this trend. Kalorama...Published: August 17, 2017 | Price: $1,200.00 – $2,400.00
Big Data in Healthcare Big Data in Healthcare looks at selected current and future applications of Big Data within the healthcare industry, including usage in IT in in vitro diagnostics, personalized medicine, pharmaceutical industry, electronic medical records (EMR), mobile health (mHealth), and the health insurance industry. Big Data in Healthcare also presents information on the following Big Data developments: selected IVD industry IT/Big Data investments, selected IT innovations in molecular diagnostics, selected genomic tests for inherited diseases, selected digital imaging...Published: June 25, 2025 | Price: $5,600.00 – $8,000.00
Updated quarterly (four times a year) to reflect market changes Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape. Leveraging over two decades of...Published: September 22, 2023 | Price: $6,000.00 – $12,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report...Published: October 12, 2017 | Price: $4,796.00 – $9,600.00
Published: February 1, 2012 | Price: $2,500.00 – $5,000.00
Vaccines are among the top revenue earners in recent years, and in some cases have assisted major pharmaceutical companies to revenue growth. But this is not without some trade-offs. Vaccines involve a complex production process. Is vaccine-making profitable? How much is the industry spending? How much is handed off to other companies and how much is made by the branded manufacturers? How many doses are produced by the industry? These are the type of questions that Kalorama Information has taken...Published: October 18, 2023 | Price: $6,000.00 – $12,000.00
Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and healthcare-related laboratories, including clinical and analytical laboratories. These include research and development labs, in-process testing labs and quality assurance labs. This new report from Kalorama Information, World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027, examines the current and potential world opportunity for healthcare laboratory information system (LIS) software, hardware, and implementation....Published: July 1, 2004 | Price: $895.00 – $1,790.00
Alternative routes of administration for insulin has been one of the leading drivers of drug delivery industry. Although transdermal and transmucosal systems have shown promise and true oral delivery remains a goal, pulmonary delivery has emerged as the leading area of development. Several major players in the pharmaceutical industry have given their backing to inhaled insulin projects, and product launches are imminent. However, the exact make-up of the market, patient acceptance, and regulatory progress are still not completely clear. This...